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Abstract:  Kappa Opioid Peptide Receptor (KOPr) activation produces analgesic, psychotomimetic, diuretic and 
antipruritic  effects.  KOPr  ligands  are  investigated  for  their  potential  roles  in  the  treatment  of  addiction, 
depression, feeding behavior, psychosis and schizophrenia. In this study the methanolic extracts of a number of 
Salvia species which are native to Turkey (S. tomentosa, S. tchihatcheffii, S. rosifolia, S. dichroantha and S. 
sclarea) were tested for their potential binding to opioid receptors in rat brain membranes and Chinese Hamster 
Ovary Cells expressing human KOPr (CHO-KOPh). [
3H]Diprenorphine, an unselective opioid antagonist, was 
utilized in the radioligand receptor binding assays. All extracts (0.11 mg/mL) inhibited the [
3H]Diprenorphine 
binding with ranging KOPr binding affinities. More than 50% inhibition of diprenorphine binding was shown 
only with Salvia dichroantha and Salvia sclarea both in rat brain membranes and CHO-KOPh membranes. 
Among them Salvia sclarea deserves further investigation for its active component(s) and its pharmacological 
characterization.  This  study  clearly  demonstrates  the  potential  opioid  receptor  binding  activities  of  several 
Turkish Salvia species. This work constitutes the first study on in vitro opioid receptor binding activities of 
Salvia species from the Turkish flora. 
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1. Introduction 
Classical  opioid  pharmacology  mainly  arose  from  the  isolation  and  characterization  of 
alkaloids, such as morphine, from the opium poppy plant Papaver somniferum. Endogenous opioid 
peptides, the plant derived opioid alkaloids as well as their synthetic derivatives target the opioid 
receptors which are the important members of G-Protein Coupled Receptors. Four structurally similar 
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but  pharmacologically  different  opioid  receptors  have  been  discovered.  Mu,  Delta,  Kappa  and 
Nociceptin/Orphanin FQ peptide receptors are mainly localized in the central nervous system as well 
as the peripheral nervous system. The activation of the mu opioid receptor is mainly responsible for 
the analgesic and euphoric effects. Compounds acting on the mu opioid receptors have a limited use 
due to the tolerance-dependence to their effects, their abuse liability as well as the high risk of the 
respiratory  depression  [1].  Kappa  opioid  receptor  activation  is  responsible  for  the  analgesic  and 
dysphoric  effects.  Kappa  opioid  receptor  is  recently  investigated  for  its  potential  roles  in  the 
behavioral responses in substance abuse, depression, learning and memory [2]. 
In the 1960s, a novel member of the Lamiaceae family, Salvia divinorum, was discovered [3]. 
Traditionally, the leaves (by chewing or smoking) are used for its hallucinogenic effects for spiritual 
divination and also as a remedy for diarrhea, headache and rheumatism especially in Oaxaca, Mexico 
[4]. The isolation of the active component, salvinorin A, from the leaves of Salvia divinorum [5] 
started a new era in hallucinogenic compounds due to its unique non-nitrogenous chemical structure. 
Salvinorin A is the first non-nitrogenous diterpene that interacts very selectively with the KOPr and 
possesses  psychotomimetic  properties  [2].  It  is  still  legal  to  use  S.  divinorum  extracts  in  many 
countries [6] and there is a large amount of work focusing on its pharmacological effects. Previously, 
in the tail flick assay, the antinociceptive property was shown to be mediated by the KOPr; also it has 
been shown that salvinorin A has a hypothermic effect and an anti-diarrheic effect mediated by the 
KOPr [7]. It has been postulated that Kappa Opioidergic System may have a role in mood disorders 
and there are reports indicating that salvinorin A produces depressive-like behavior [8]. On the other 
hand, one report exists for its use in refractory depression [9]. Sedation and loss of motor coordination 
produced by salvinorin A have also been shown [10]. Besides salvinorin A, several similar compounds 
(Salvinorin B-J) have been obtained from S. divinorum [11-14]. However, salvinorin A remains to be 
the most potent and effective, thus taken as a template compound for structure-activity studies for 
further synthesis of synthetic analogs [15,16]. 
Salvia  (sage),  the  largest  genus  of  the  family  Lamiaceae,  consists  of  approximately  900 
species which are distributed throughout the world [17]. The flora of Turkey is rich in Salvia species 
(commonly known as “adacayi”) and is represented by around 90 species, half of which are endemic 
[18].  Sage  species  are  traditionally  used  as  herbal  teas  in  Turkey.  Some  of  these  species  are 
spasmolytic, carminative, diuretic, antiseptic, and wound healing, as well as being used against colds 
[19]. In addition, aerial parts or leaves of several Salvia species are reported to be used to relieve 
various  types  of  pain  in  Turkish  traditional  medicine,  i.e.,  rheumatic  pain,  headache,  toothache, 
abdominal pain, stomachache. Among these species the leaves of S. tomentosa are used to alleviate 
rheumatic  pain  [20]  and  abdominal  pain  [21],  leaves  of  S.  dichroantha  are  reported  to  reduce 
abdominal pain [22] and aerial parts of S. sclarea to relieve pain in sunstroke [23]. 
In this study, we aimed to investigate the possible opioid receptor binding activity of five 
Salvia species (S. tomentosa Miller, S. dichroantha Stapf., S. sclarea L. S. tchihatcheffii Boiss. and S. 
rosifolia Sm.) in rat brain membranes and cells expressing KOPr. To our knowledge, there is no in 
vitro receptor binding study performed on Turkish Salvia species as a first step for screening their 
opioid activity. 
 
2. Materials and Methods 
 
2.1. Plant Material  
 
Salvia tomentosa, S. dichroantha (endemic) and S. sclarea were collected in July 2008 from 
Eskisehir, Turkey while S. tchihatcheffii (endemic) and S. rosifolia (endemic) were collected in July 
2006 from Ankara and Bayburt, respectively. The plant materials were identified by Dr. Akaydin and 
the voucher specimens (Akaydın 10934, 10539, 11086, 11812 and 11028, respectively) have been 
deposited at the Herbarium of the Faculty of Education, Hacettepe University, Ankara, Turkey. 
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2.2 Chemicals 
[
3H]Diprenorphine  (specific  activity  33  Ci/mmol)  was  purchased  from  Amersham  GE 
HealthCare,  UK.  Diprenorphine  and  Salvinorin  A  are  products  of  Tocris  and  Sigma-Aldrich, 
respectively. Tris-hydroxymethyl-aminomethane was purchased from Sigma-Aldrich. Methanol was 
provided  from  Merck  Co.,  Darmstad.  (-)  Ethylketocyclozocine  ((-)EKC),  ((2alpha,6alpha,11S*)-3-
(Cyclopropylmethyl)-6-ethyl-3,4,5,6-tetrahydro-8-hydroxy-11-methyl-2,6-methano-3-benzazocin-
1(2H)-one) is a kind gift from Dr. Anna Borsodi (Hungary). 
 
2.3. Preparation of the extracts  
The air-dried and powdered leaves of each plant (1 g) were extracted with Methanol (10 mL) 
at 45 °C for 2 hours. After filtration, methanolic extracts were dried under vacuum. The extract yield 
was  as  follows:  15%  for  S.  tomentosa,  13%  for  S.  dichroantha,  15%  S.  sclarea,  16%  for  S. 
tchihatcheffii and 12% for S. rosifolia. 
 
2.4. Animals 
Inbred Wistar rats (Animal vivarium of the Yeditepe University, Istanbul, Turkey) were used 
throughout  this  study.  Rats  were  kept  four  per  cage,  allowed  free  access  to  food  and  water  and 
maintained on a 12/12-hour light/dark cycle until the time of sacrifice. Animals were treated according 
to the guidelines published in the European Communities Council Directives (86/609/ECC) and the 
Turkish Act for the Protection of Animals in Research (Regulation No. 25464) and the protocols were 
approved by the ethical committee of Yeditepe University (YUDETAM). 
 
2.5. Membrane preparation  
Wistar rats were decapitated and brains without cerebellum were quickly removed and washed 
several times with chilled 50 mM Tris-HCl buffer (pH 7.4), homogenized and filtered through four 
layers of gauze to remove large aggregates. The homogenate was centrifuged at 40,000 g (18,200 rpm) 
for 20 min at 4 °C. Pellet was re-suspended in fresh 50 mM Tris-HCl buffer and incubated for 30 min 
at 37 °C. The centrifugation step was repeated and the final pellets were resuspended in 50 mM Tris-
HCl buffer (pH 7.4) and stored at -70°C. 
Chinese Hamster Ovary cells stably expressing the wild type human Kappa Opioid Peptide 
receptor and Mu Opioid Peptide receptor (CHO-MOPh) were cultured in a medium containing Nut 
Mix F-12 (HAM) with L-glutamine (GIBCO Invitrogen) and 25 mM Hepes, 10 % FCS, 100 UI/mL 
penicillin,  100  µg/ml  streptomycin  and  0.4  mg/mL  G418  at  37  ºC  in  a  humidified  atmosphere 
consisting of 5 % CO2 and 95 % air. Cells were sub-cultured twice a week and harvested with ice cold 
phosphate Buffered Saline (PBS), frozen at -70 °C for 2 hours to facilitate cell disruption by water 
crystallization in 50 mM Tris-HCl (pH 7.4). Membrane was prepared as indicated above. 
 
2.6. Competition Binding Assays  
Aliquots of frozen membranes (60-80 µg protein/well) were thawed, and suspended in 50 mM 
Tris-HCl buffer (pH 7.4) and incubated with gentle shaking for 50 min, 24 °C in a final volume of 200 
µl with the unlabelled compounds (10
-5-10
-13 M) and/or extracts (0.11-0.00011 mg/ml) and ~1 nM 
[
3H]Diprenorphine (33 Ci/mmol, Amersham). The highest concentration of the extracts contains 1 % 
of  methanol  which  has  no  interference  with  the  binding  parameters.  Non-specific  binding  was 
determined in the presence of 10
-5 M diprenorphine. The reaction was terminated by rapid filtration 
under vacuum (harvester 96 Mach III, TOMTEC) and washed with ice cold 50 mM Tris-HCl (pH 7.4) Opioid receptor binding activities of Salvia Species 
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buffer through GF/B  glass  fiber filters  (Filtermat B 1450-521  Perkin  Elmer). Filtermat was dried 
overnight and bound radioactivity was measured in an 8 mL Betaplate scint scintillation cocktail using 
a  1450  Microbeta  Trilux  Liquid  Scintillation  and  Luminescence  counter  (Perkin  Elmer).  Protein 
concentration was measured by the Bradford method with bovine serum albumin as the standard [24]. 
 
2.7. Data Analysis  
Data were analyzed with GraphPad Prism (version 5.0) by non-linear regression using the one-
site  competition  fitting  option.  IC50 (the concentration  of  the  competing ligand  or  extract at  50% 
inhibition of the specific binding) values were obtained from the displacement curves. Non-specific 
binding was subtracted from the total binding (in absence of ligand) and the specific binding was 
found. All receptor binding data are expressed as percentage inhibition of specific binding and are the 
means ± S.E.M. of the result of at least three independent experiments performed in duplicate. 
 
3.  Results and Discussion   
Receptor binding experiments were performed with 0.8 ± 0.1 nM [
3H]Diprenorphine, a non-
selective opioid receptor antagonist, on membranes from rat brain and cultured cells transfected with 
human KOPr. Reference compounds diprenorphine, ethylketocyclazocine (a full agonist of KOPr, pKi 
10  [25]),  and  salvinorin  A  were  also  used  to  compete  for  the  [
3H]Diprenorphine  binding  sites. 
Methanolic  extracts  prepared  from  the  leaves  of  five  Salvia  species  were  able  to  displace  the 
[
3H]Diprenorphine  binding  with  variable  affinities.  IC50  values  are  summarized  in  Table  1a  for 
compounds and 1b for the extracts. Heterologous displacement binding curves (Fig. 1) for each extract 
and  salvinorin  A  were  sufficiently  fitted  with  the  one-site  binding  model.  In  a  brain  membrane 
preparation a mixed population of receptors is present; however the recombinant systems are “purer 
systems” that carry only the desired receptor DNA and thus have only one type of receptor highly 
expressed. Therefore, in order to identify the specificity and selectivity of the opioid receptor binding, 
[
3H]Diprenorphine binding experiments were performed on membranes from Chinese Hamster Ovary 
cells expressing human KOPr (Fig. 1 C, 1 D). The two extracts from S. dichroantha and S. sclarea 
exhibited more than 50% binding to KOPr.  
 
Table 1. The summary of the IC50 values obtained from the competition displacement binding curves for the 
ligands (a) and extracts (b). Inhibition (%) of the [
3H]Diprenorphine binding with the extracts (0.11 mg/mL) and 
ligands (10
-5 M) are also shown. % displacement values are indicated with the S.E.M. (standard error of mean) 
values. (n.d.: not determined) 
 
a) 
Ligand  Rat Brain Membranes  CHO-KOPh Membranes 
IC50 nM  % inhibition at 10
-5 M
  IC50 nM  % inhibition at 10
-5 M
 
Diprenorphine  0.02  100 ± 0  0.26  100 ± 0 
(-) Ethylketocyclozocine  n.d.   n.d.   0.35  99.4 ± 0.6 
Salvinorin A  0.35  53.2 ± 6.7  5.1  87.9 ± 1.7 
 
b) 
Extract  Rat Brain Membranes  CHO-KOPh Membranes 
IC50 mg/mL  % inhibition at 0.11 mg/mL  IC50 mg/mL  % inhibition at 0.11 
mg/mL 
S. tomentosa   0.01  37.1 ± 7.5  0.52  32.5± 18.5 
S. tchihatcheffii  0.82  48.7 ± 4.6  0.21  40.0 ± 7.8 
S. rosifolia  0.06  40.2 ± 5.6  0.06  57.3 ± 11.6 
S. dichroantha  0.18  64.3 ± 2.9  0.001  45.2 ± 11.6 
S. sclarea  0.27  60.2 ± 8.0  0.04  68.2 ± 2.4 
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The rank order of affinities and % inhibition is summarized in Table 1a and b. The affinity of 
salvinorin A in rat brain and CHO-KOPh membranes are in good agreement with the literature data 
[2]. Due to the extract compositions there can be many different compounds present; thus the affinities 
of the extracts are much lower when compared to the pure compounds. Mu Opioid Peptide receptor 
(MOPr)  binding  in  CHO-MOPh  cells  were  performed  but  the  binding  of  the  extracts  was  not 
detectable due to the shallow curves and thus the data are not shown. The problem with the shallow 
binding curves could not be overcome with increasing the extract concentrations possibly due to the 
higher organic solvent content which may cause membrane perturbation, which may affect the overall 
results.  
 
 
Figure 1. Displacement binding curves of salvinorin A, diprenorphine, S. dichroantha, S. sclarea in rat brain 
membranes (A, B) and in membranes from CHO-KOPh cells (C, D). [
3H]Diprenorphine (0.8 ± 0.1 nM) was 
incubated  (50  min,  24  °C)  in  the  presence  of  increasing  concentrations  of  competitor  ligands  and  extracts 
indicated in the figure. Points represent the mean ± S.E.M. of at least three different experiments each performed 
in duplicate. 
 
 
The IC50 value of S. tomentosa is increased in CHO-KOPh membrane system. This may be 
due  to  the  low  capacity  %  inhibition  of  S.  tomentosa  at  the  highest  concentration  used  in  the 
experiment in the recombinant and cellular system with [
3H]Diprenorphine. Indeed the low IC50 (high 
affinity)  values  in  rat  brain  membrane  might  indicate  other  targets  than  Kappa  Opioid  Peptide 
Receptors, since [
3H]Diprenorphine is a non-selective opioid receptor ligand. All of the other extracts 
have lower IC50 and higher % inhibition values that reflect the specificity of the binding towards kappa 
opioid peptide receptor. The order of specificity in terms of binding to the KOPr is S. sclarea > S. 
rosifolia > S. dichroantha > S. tchihatcheffii > S. tomentosa. The incomplete displacement binding 
curves  observed  with  the  extracts  as  well  as  Salvinorin  A,  both  in  rat  brain  and  CHO-KOPh 
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membranes, may be due to i) possible allosteric binding to receptors, ii) the complex nature of the 
extracts with chemical diversity. In rat brain membranes the incomplete displacement binding curves 
may also be, in addition to the ones noted above, due to the possible non-specific interactions which 
may be a result of the non-selective opioid receptor antagonist ([
3H]Diprenorphine) that was used in 
this study. 
In  this  paper,  we  have  investigated  the  in  vitro  opioid  receptor  binding  activity  of  crude 
methanolic  extracts  of  five  Salvia  species,  three  of  which  are  endemic  to  Turkey.  Among  these 
species, S. sclarea, S. tomentosa and S. dichroantha were selected based on their traditional utilization, 
including reported alleviation of various types of pain in Turkish folk medicine [21,22], while S. 
tchihatcheffii and S. rosifolia are endemic species not known for any healing features. Previously 
Salvinorin A was shown to inhibit only partially the [
3H]Diprenorphine binding [27]. This study has 
clearly demonstrated that these two species may produce their pain-relieving effect at least to some 
extent through opioid receptors. 
Previous phytochemical studies on Salvia species indicated the presence of diterpenes and 
phenolic compounds as the chief secondary metabolites [17]. The pharmacological activities of the 
Salvia  species  are  mostly  attributed  to  their  diterpene  contents,  as  in  the  case  of  S.  divinorum 
(salvinorin A) and S. miltiorrhiza (tanshinones) [28]. Eventually, the opioid receptor binding activities 
of the extracts may arise from the diterpenoid component of these species. The most active species, S. 
sclarea and S. dichroantha need further investigation for the identification of the active components 
responsible for this activity. There are only a few studies in the literature that were performed on 
several Salvia species; Li and colleagues observed no significant binding to any of the opioid receptors 
with  the  compounds  isolated  from  S.  splendes  (splendindin)  and  S.  farinacea  (salvifaricin)  [29]. 
Moreover, S. leriifolia and S. miltiorrhizae have been shown to possess antinociceptive effects claimed 
to be mediated by opioid receptors [30, 31]. The pharmacological effects of Salvia species on the 
central nervous system are summarized in a review [28].  
Morphine  is  one  of  the  classical  examples  of  the  use  of  natural  plant  sources  as  the 
pharmacologically active remedies for many diseases. It is a partial agonist acting on the mu opioid 
receptor and the most well known analgesic drug in the world. Almost all the drugs acting on the 
opioid receptors have a morphinan structure (with nitrogenous heterocyclic group). This structure is 
conserved as the distance between the aromatic group and the nitrogen even in the opioid peptides and 
the presence of the positively charged nitrogen atom was an assumed requirement for the interaction 
with opioid receptors [32]. Due to the conserved structure of the opiates, besides the analgesic effect, 
the undesirable side effects like tolerance and dependence and abuse potential emerge, thus their usage 
is limited and the undesired side effects are believed to be related to the classical morphinan structure. 
In 1994, a neocleredane diterpene (salvinorin A), the first non-nitrogenous hallucinogenic compound, 
was isolated from S. divinorum and can bind with high affinity to KOPr [5]. The Kappa Opioidergic 
system is mainly associated with hallucinations in mood disorders or schizophrenia and Alzheimer’s 
disease. Salvinorin A is also an allosteric modulator of the MOPr [27]. Allosteric modulators are 
becoming more and more popular for their potential in drug development [33]. Salvinorin A is one of 
the  few  allosteric  modulators  of  opioid  receptors;  therefore  its  structure  deserves  attention  for 
templates  of  novel  ones.  The  non-classical  diterpenoid  structure  with  the  allosteric  modulator 
capability of salvinorin A and similar compounds that are isolated from other Salvia species, can be 
lead structures for novel ligands acting on mainly opioid receptors. As stated by Christopoulos (2002) 
[26],  in  contrast  to  orthosteric  ligands,  an  allosteric  compound  may  have  no  apparent  effect  on 
orthosteric radioligand binding even when it showed prominent allosteric modulation on the signaling. 
Moreover in a plant extract there are no simple pure compounds but rather those with more complex 
chemical structures. Therefore our results may not rule out the possibility of diterpenoid content and 
the allosteric capability of the extracts to the Mu Opioid Receptor. It is well known that diterpenes are 
common in the genus Salvia [34, 35]. The structural diversity of the diterpenes within the genus Salvia 
varies greatly. So, the structures of the diterpenes which could be present in the non-active extracts 
might be different from those of S. sclarea and S. dichroantha. Although several triterpenoids and 
diterpenoids have been reported from the roots of S. dichroantha [35] and S. sclarea [36], their aerial 
parts  have  been  less  investigated.  If  a  greater  number  of  novel  compounds  from  different  Salvia Gündüz Çınar et.al., Rec. Nat. Prod. (2011) 5:4 281-289 
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species  are  identified,  more  receptor  specific  interactions  and  better  ligands  can  be  designed. 
Therefore it would be intriguing to perform structural elucidation of the active components in these 
Salvia species, in particular the Salvia sclarea. 
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